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ABSTRACT 
Objective: To compare anticonvulsant activity of methanol extracts of Sapindus emarginatus (MESE) and Acorus calamus (MEAC) in experimental 
seizure models in mice. 
Methods: Hind limb tonic extension (HLTE) in Maximal electroshock (MES) seizure and clonic seizure in Pentylenetetrazol (PTZ) seizure models 
were assessed. Group I (control) mice received 1% gum acacia in distilled water (1 ml/100 g). Topiramate (50 mg/kg) was administered in group II 
(standard) animals. Group III and IV mice were treated with 200 and 400 mg/kg of MESE, respectively. Mice in group V and VI were given MEAC at 
the dose of 200 and 400 mg/kg, respectively. Drugs were given orally suspended in 1% gum acacia suspension (1 ml/100 g) for 7 d. Next day after 1 
h of drug administration, the seizure was induced for evaluation. 
Results: Anticonvulsant property of both extracts was confirmed by reduction (p<0.001) in HLTE phase in MES model; delayed onset of the clonic 
seizure (p<0.001) and its shortened phase (p<0.001) in PTZ model when compared with the control. MESE-200 mg/kg produced significantly 
longer (p<0.001) HLTE phase with lower protection (40.34%) among the different doses of the extracts. Clonic seizure onsets and durations in PTZ 
model were comparable among the different extract-treated groups; however, mortality was higher (66.6%) with MESE-200 mg/kg. 
Conclusion: Anticonvulsant activity of MESE and MEAC was evident; however, MESE at the dose of 200 mg/kg was less effective. 
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INTRODUCTION 
Epilepsy is one of the common serious neurological disorders 
associated with substantial morbidity and mortality due to seizures 
and available medications [1]. The seizures arise from an excessively 
synchronous and sustained discharge of an aggregate of 
neurons in the brain [2]. The pathologies leading to epilepsy can 
occur anywhere in the circuit level in brain e. g. from abnormal 
synaptic connectivity to the receptor level, abnormality of γ-amino 
butyric acid (GABA) receptor subunits and/or ion channel 
dysfunction [3]. 
The antiepileptic drugs are often associated with debilitating 
adverse effects. The toxicity, intolerance and lack of efficacy are the 
limitations of the drugs. Therefore, the main goal in epilepsy 
research is the development of new agents which can overcome 
these limitations [4]. Many natural and synthetically modified 
natural products have been successfully developed to treat human 
diseases in almost all therapeutic areas [5]. The literature reveals 
that many medicinal plants are used in different systems of 
complementary and alternative medicines for the treatment of 
various ailments, including mood disorders and epilepsy [6]. 
Sapindus emarginatus Vahl. [7] and Acorus calamus Linn. [8] are 
among the medicinal plants reported to possess antiepileptic 
property. The present study attempts to compare the anticonvulsant 
activity of the two plants on experimental seizure models in mice, 
which are commonly used because of smaller size, the genetic, 
biological and behavioural characteristics closely resemble to 
human. 
MATERIALS AND METHODS 
The study was conducted in the Department of Pharmacology, 
Regional Institute of Medical Sciences (RIMS), Imphal after getting 
approval of the Institutional Animal Ethics Committee 
(No.1596/GO/a/12/CPCSEA). 
Requirements 
Albino mice, polypropylene cages, gavage feeding tube, electro-
convulsiometer, ear clip electrodes, pentylenetetrazol, topiramate, 
stopwatch, markers, needles and syringes, distilled water, gum 
acacia (Hi Media Laboratories Pvt. Ltd, Mumbai, India), petroleum 
ether (Hi Media Laboratories Pvt. Ltd, Mumbai, India), methanol 
(Merk Specialities, Pvt. Ltd. Mumbai), soxhlet apparatus (Garg 
Process Glass India Pvt. Ltd. Malad, Mumbai), mixer grinder, 
evaporating dish, weighing machine (Shimadzu, corporation, Japan), 
mortar and pestle. 
Preparation of plant extract  
The collected leaves of Sapindus emarginatus Vahl. and Acorus 
calamus Linn. from the Imphal valley were identified and 
authenticated by Prof. P. K. Singh, Department of Life Sciences, 
Manipur University (Acc. no. MUMP-0197 and 1423). The plant 
extraction was done following principles adopted by Lin J et al. [9]. 
The shade dried powdered leaves were defatted with petroleum 
ether and extracted with methanol using soxhlet apparatus 
separately. The extracts obtained were evaporated and stored in 
airtight containers. The yield obtained was 10% and 6% for 
Sapindus emarginatus and Acorus calamus, respectively. 
Phytochemical screening 
The preliminary phytochemical studies of the extracts were done 
using standard procedures [10, 11]. 
Acute toxicity testing 
The acute toxicity testing was done as per OECD guidelines 423 [12] 
in albino mice. Three animals were used in each step. The methanol 
extracts of leaves of Sapindus emarginatus (MESE) and Acorus 
calamus (MEAC) were administered to the fasted mice at a dose of 
300 mg/kg orally (p. o.) followed by observation once in every 30 
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min during the first 24 h, and then daily for 14 d. As there was no 
mortality, the same procedure was repeated with the higher dose of 
2000 mg/kg. No mortality or toxic symptom was detected in the 
animals. The doses of 200 and 400 mg/kg of the extracts were 
chosen for the study. 
Experimental animals 
Healthy albino mice of either sex weighing 25-30 g were obtained 
from the animal house, RIMS, Imphal. The mice were housed in 
polypropylene cages and acclimatized to the laboratory conditions 
for 7 d at room temperature with natural light and dark cycle. They 
were maintained on standard diet with water ad libitum. 
Experimental design  
For both the MES and PTZ seizure models, selected mice were 
divided into six groups (I, II, III, IV, V and VI) of 6 mice in each. The 
mice in group I (Control) received 1% gum acacia in distilled water 
(DW) at the dose of 1 ml/100 g orally. The group II (Standard) 
animals were administered Topiramate-50 mg/kg (Sun Pharma 
Laboratories Ltd. East Sikkim, B. No BSR 0857). The mice in group III 
and IV were treated with 200 and 400 mg/kg of MESE, respectively. 
The group V and VI mice were given 200 and 400 mg/kg of MEAC, 
respectively. The standard drug and the plant extracts were 
suspended in 1% gum acacia in DW and administered at the dose of 
1 ml/100g/day orally for 7 consecutive days. The next day after 1h 
of drug administration, seizure was induced for evaluation. Each 
mouse was tested only once. 
Maximal electroshock (MES) seizure model 
Selection of animals 
Electroconvulsiometer (Techno Electronics, Lucknow) was used for 
seizure induction. The mice showing hind limb tonic extension (HLTE) 
at a current of 50 mA for 0.2 sec via a pair of ear clip electrodes were 
selected. HLTE was defined by extension of hind limb more than 90° 
from the body and sustained for more than 3 seconds [13]. A recovery 
period of 5 d was given before the main test. 
Procedure 
The mice were subjected to an electrical stimulus of 50 mA of 
alternating current from the electroconvulsiometer for 0.2 sec via ear 
clip electrodes. The resulting seizure passed through different phases-
tonic flexion, tonic extension, clonic convulsions, stupor, and recovery 
or death [14]. The reduction or complete of abolition of HLTE phase 
was considered as protection action against convulsion [15]. The HLTE 
phase and its percentage protection were assessed. The percentage of 
protection was calculated using the following equation [16]. 
 
Pentylenetetrazol (PTZ) seizure model 
The mice in the different groups were treated as per the 
experimental design for 7 consecutive days. The next day after 1h of 
the drug treatment, the animals were injected 1% PTZ (HI Media 
Lab. Pvt. Ltd. Batch No. GRM1742-25G) in DW at the dose of 100 
mg/kg subcutaneously in the scruff of the neck and observed. There 
was a sequence of excitement, myoclonic jerks, clonic seizures, one 
or more maximal tonic seizure followed by recovery or death. The 
development of clonic seizure with loss of righting reflex was taken 
as a positive seizure response [15] and its abolition or suppression 
was taken as protection against PTZ seizures. The mortality, time of 
onset of clonic seizure (seizure latency) and its duration in the 
different groups were recorded. The percentage reduction of the 
clonic phase [16] was calculated as follows. 
 
Analysis of results 
The results obtained were expressed as mean±standard deviation 
(SD) and analysed by One-way analysis of variance (ANOVA) 
followed by Bonferroni test. P<0.05 was considered significant. IBM 
SPSS statistics version 21 was used for data analysis. 
RESULTS 
Phytochemical screening 
The qualitative phytochemical analysis of MESE and MEAC detected 
the presence of alkaloids, flavonoids, saponins and tannins. In 
addition, the MESE and MEAC revealed the presence of protein and 
starch, respectively. 
MES seizure model 
The HLTE phase (sec) in the groups receiving 1% gum acacia (control), 
Topiramate-50 mg/kg (standard), MESE-200 mg/kg, MESE-400 
mg/kg, MEAC-200 mg/kg and MEAC-400 mg/kg were 21.32±1.8, 
7.55±1, 12.72±0.4, 8.13±0.7, 8.28±0.7 and 8.26±0.6 respectively. The 
HLTE phases were reduced (P<0.001) in all the drug-treated groups 
when compared with the control group. The HLTE durations among 
the standard, MEAC and MESE-400 mg/kg treated groups were not 
significantly different. But MESE-200 mg/kg showed significantly 
longer (P<0.001) HLTE phase than all the groups except the control 
group. The percentage protection of HLTE (table 1) was 64.58 
(standard), 40.34 (MESE-200 mg/kg), 61.86 (MESE-400 mg/kg), 61.16 
(MEAC-200 mg/kg) and 61.25 (MEAC-400 mg/kg). 
 
Table 1: Effect on HLTE in maximal electroshock seizure model 
Treatment group HLTE (sec) % protection 
I. Control-1%gum acacia in DW. 21.32±1.84 - 
II. Topiramate-50 mg/kg 7.55±0.99*† 64.58 
II. MESE-200 mg/kg 12.72±0.44* 40.34 
V. MESE-400 mg/kg 8.13±0.69*‡ 61.86 
V. MEAC-200 mg/kg 8.28±0.67*‡ 61.16 
VI. MEAC-400 mg/kg 8.26±0.59*‡ 61.25 







Values are mean±SD. n=6, *P˂0.001 when compared with control, †P˂0.001 when compared with MESE-200 mg/kg, ‡P˂0.001 when compared with 
MESE-200 mg/kg. (One way ANOVA followed by Bonferroni test). 
 
Pentylenetetrazol (PTZ) seizure model 
The onset of clonic seizure (sec) in the control, Topiramate, 
MESE-200 mg/kg, MESE-400 mg/kg, MEAC-200 mg/kg and 
MEAC-400 mg/kg groups were 119.3±6.3, 390±30, 237±1.4, 
239±2.4, 232±2.0 and 232±2.3 respectively. There was 
significant (P<0.001) delay in the onset in the Topiramate, MESE 
and MEAC treated groups when compared with the control 
group; however, it was not significantly different among the 
extract-treated groups. The clonic phases (sec) in the control, 
standard, MESE-200 mg/kg, MESE-400 mg/kg, MEAC-200 mg/kg 
and MEAC-400 mg/kg groups were 21.36±2.1, 5.08±4.1, 
10.58±5.2, 8.46±0.8, 8.20±3.4 and 6.90±6.1 respectively. It was 
shortened (P<0.001) in the Topiramate, MESE and MEAC treated 
groups when compared with the control group, but the durations 
were comparable in the Topiramate and extract-treated groups. 
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The percentage reduction of clonic phase in the different groups 
was 76.22 (standard), 50.46 (MESE-200 mg/kg), 60.39 (MESE-
400 mg/kg), 61.61 (MEAC-200 mg/kg) and 67.70 (MEAC-400 
mg/kg). Topiramate provided a maximum reduction of the clonic 
phase with least mortality (16.6%) among the groups, while 
MESE-200 mg/kg showed highest (66.6%) mortality (table 2). 
 
Table 2: Effect on clonic seizure in pentylenetetrazol seizure model 
Treatment group Clonic seizure onset (sec) Duration of clonic seizure 
(sec) 
% reduction of 
clonic phase 
% mortality 
I. Control-1% gum acacia in DW  119±6.38 21.36±2.12 - 100 
II. Topiramate-50 mg/kg 390±30.02*† 5.07±4.08* 76.22 16.6 
II. MESE-200 mg/kg 237±1.47* 10.58±5.19* 50.46 66.6 
V. MESE-400 mg/kg 239±2.42* 8.46±0.76* 60.39 33.3 
V. MEAC-200 mg/kg 232±2.04* 8.20±0.76* 61.61 50 
VI. MEAC-400 mg/kg 232±2.33* 6.90±3.44* 67.70 50 














The suitable animal models are used to study various human disorders 
including seizures and behavioural disorders. Mice have commonly 
used rodents because of small size, ease of housing and maintenance. 
Interestingly, the genetic, biological and behavioural characteristics of 
the rodents closely resemble those of humans [17]. The MES and PTZ 
induced seizure models are considered gold standards in the 
evaluation of anticonvulsant activity in the early stages of testing [4]. 
For predictability of the results, it is important to obtain coherent 
findings in the different models, and at least two methods are often 
recommended as congruent findings are not always obtained between 
the methods [18]. The MES model identifies agents with activity 
against generalized tonic-clonic seizures, whereas the PTZ model 
identifies compounds that are efficacious against generalized absence 
and myoclonic seizures [19, 20]. 
Topiramate acts through multiple mechanisms such as inhibition of 
voltage-dependent sodium and calcium currents, potentiation of 
GABA-mediated events, blockade of glutamatergic neurotransmission 
and enhancement of potassium currents [21]. The observation of the 
already proven effect of topiramate as an anticonvulsant drug proved 
the validity of the experimental design followed.  
The reduction of HLTE phase in the MES model; significantly delayed 
onset and shortened duration of clonic seizure in PTZ model 
revealed the anticonvulsant properties of MESE and MEAC. The 
methanol extract of leaves of Sapindus emarginatus at the dose of 
200 mg/kg was less effective as evident by the lower percentage of 
protection of THLE in MES model and higher percentage mortality 
the PTZ seizure model. 
It is known that the MES induced seizures are abolished by the drugs 
that block voltage-gated Na+channels [22] or by the drugs that block 
the glutamatergic receptor [23]. The PTZ induced seizures are 
prevented by drugs that reduce T-type Ca2+ currents and also by 
drugs that enhance gamma-aminobutyric acid (GABA) mediated 
inhibitory neurotransmission [20, 22]. 
Literature review reveals that various classes of the phytochemicals such 
as saponins [24], flavonoids [24], terpenes, alkaloids, lactones and 
coumarins [25] exhibit anticonvulsant property. Therefore, the observed 
anticonvulsant effects of the two plants could be attributed to the 
alkaloids, flavonoids, saponins and tannins present in the extract. The 
prevention of the MES and PTZ induced seizures suggests that the 
methanol extract of Sapindus emarginatus and Acorus calamus act by 
multiple mechanisms, possibly by blocking of voltage-gated Na+channels 
or glutamatergic receptors, and/or enhancement of GABAergic 
neurotransmission or reduction of T-type Ca2+currents in the brain.  
CONCLUSION 
The findings of our study reveal that the methanol extracts of 
Sapindus emarginatus and Acorus calamus leaves act by multiple 
mechanisms as anticonvulsants. The Sapindus emarginatus leaf 
extract is associated with a weaker anticonvulsant effect at 200 
mg/kg dose. Further studies with isolated biologically active 
principles of the plants in the genetic models of epilepsy will be 
more meaningful and interesting.  
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